scispace - formally typeset
E

Ennio Esposito

Researcher at Mario Negri Institute for Pharmacological Research

Publications -  95
Citations -  5959

Ennio Esposito is an academic researcher from Mario Negri Institute for Pharmacological Research. The author has contributed to research in topics: Dopamine & Dopaminergic. The author has an hindex of 41, co-authored 94 publications receiving 5756 citations.

Papers
More filters
Journal ArticleDOI

A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes.

TL;DR: The biochemical mechanisms by which nutritional antioxidants can reduce or block neuronal death occurring in neurodegenerative disorders are reviewed and particular emphasis will be given to the role played by the nuclear transcription factor-kappaB (NF- kappaB) in apoptosis, and in the pathogenesis of neurodegenersative disorders, such as AD, PD, and ALS.
Journal ArticleDOI

Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.

TL;DR: The biochemical mechanisms by which nutritional antioxidants can reduce or block neuronal death occurring in neurodegenerative disorders are reviewed and particular emphasis will be given to the role played by the nuclear transcription factor -kB (NF-kB) in apoptosis, and in the pathogenesis of neurodegenersative disorders, such as AD, PD, and ALS.
Journal ArticleDOI

SB 242 084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system

TL;DR: Data indicate that the central 5- HT system exerts a tonic and phasic inhibitory control on mesolimbic DA neuron activity and that 5-HT2C receptor subtypes are involved in this effect.
Journal ArticleDOI

Role of 5-HT2C receptors in the control of central dopamine function

TL;DR: The role of 5-HT(2C) receptors in the control of brain DA function will be reviewed, and the search for new therapies for neuropsychiatric disorders, such as depression, schizophrenia and drug addiction, based on these findings will be discussed.
Journal ArticleDOI

5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.

TL;DR: The results show that 5-HT2A and 5- HT2C receptors regulate specifically the activation of midbrain DA neurons induced by amphetamine and morphine, respectively, and suggest that 4-HT1C receptors selectively modulate the impulse flow–dependent release of DA.